Tag: Howard Lyons

Latest articles

MHRA approves second monoclonal antibody COVID-19 treatment

MHRA approves second monoclonal antibody COVID-19 treatment

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved another COVID-19 treatment, Xevudy (sotrovimab), after it was found to be safe and effective...
Rizvan Batha

Personalised medication: Why dosage is so important

Rizvan Faruk Batha MPharm, PGDip GPP, IPresc, MRPharmS, Superintendent Pharmacist and Director of Operations at Specialist Pharmacy, examines the benefits of compounded and personalised...
New HIV action plan to end infections by 2030 revealed

New HIV action plan to end infections by 2030 revealed

The Department of Health and Social Care has revealed a new HIV action plan which aims to reduce new infections by 80% by 2025...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Rizvan Batha

Personalised medication: Why dosage is so important

Rizvan Faruk Batha MPharm, PGDip GPP, IPresc, MRPharmS, Superintendent Pharmacist and Director of Operations at Specialist Pharmacy, examines the benefits of compounded and personalised...
MHRA approves second monoclonal antibody COVID-19 treatment

MHRA approves second monoclonal antibody COVID-19 treatment

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved another COVID-19 treatment, Xevudy (sotrovimab), after it was found to be safe and effective...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease

MHRA approval for Astellas’ roxadustat for anaemia of chronic kidney disease

The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Astellas’ Evrenzo™▼ (roxadustat) for the treatment of adult patients with symptomatic anaemia associated with...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription